1. Home
  2. XBIT vs KRMD Comparison

XBIT vs KRMD Comparison

Compare XBIT & KRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$2.20

Market Cap

66.8M

Sector

Health Care

ML Signal

N/A

Logo KORU Medical Systems Inc. (DE)

KRMD

KORU Medical Systems Inc. (DE)

N/A

Current Price

$3.03

Market Cap

192.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
XBIT
KRMD
Founded
2005
1980
Country
United States
United States
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
66.8M
192.5M
IPO Year
2015
2019

Fundamental Metrics

Financial Performance
Metric
XBIT
KRMD
Price
$2.20
$3.03
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $6.25
AVG Volume (30 Days)
36.5K
★ 226.7K
Earning Date
11-11-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 53.85
EPS
N/A
★ N/A
Revenue
N/A
★ $41,127,366.00
Revenue This Year
N/A
$16.78
Revenue Next Year
$30.47
$17.22
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 22.23
52 Week Low
$2.09
$2.98
52 Week High
$3.44
$6.61

Technical Indicators

Market Signals
Indicator
XBIT
KRMD
Relative Strength Index (RSI) 47.52 24.92
Support Level $2.16 N/A
Resistance Level $2.48 $3.41
Average True Range (ATR) 0.04 0.13
MACD 0.01 -0.02
Stochastic Oscillator 66.67 3.06

Price Performance

Historical Comparison
XBIT
KRMD

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About KRMD KORU Medical Systems Inc. (DE)

KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.

Share on Social Networks: